Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICGeneric

OLOPATADINE HYDROCHLORIDE

OLOPATADINE HYDROCHLORIDE

Standard Dose
0.1%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: None (Tentative Approval)
Summary

Approval overview OLOPATADINE HYDROCHLORIDE is listed in Drugs@FDA under application 203416 (ANDA).

Marketing status: None (Tentative Approval) Active ingredient OLOPATADINE HYDROCHLORIDE Form and strength SOLUTION;OPHTHALMIC - 0.1% Sponsor WATSON LABS Submission history Latest submission status date: 2015-02-02 00:00:00.

Structured Monograph

Clinical summary

Approval overview OLOPATADINE HYDROCHLORIDE is listed in Drugs@FDA under application 203416 (ANDA). Marketing status: None (Tentative Approval) Active ingredient OLOPATADINE HYDROCHLORIDE Form and strength SOLUTION;OPHTHALMIC - 0.1% Sponsor WATSON LABS Submission history Latest submission status date: 2015-02-02 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: None (Tentative Approval)

Interaction Notes

  • No interaction notes stored yet.